MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Progesterone for Smoking Relapse Prevention Following Delivery

Phase 2
Completed
Conditions
Tobacco Use Disorder
Interventions
Drug: Placebo
First Posted Date
2013-10-30
Last Posted Date
2018-01-17
Lead Sponsor
Yale University
Target Recruit Count
41
Registration Number
NCT01972464
Locations
🇺🇸

Yale School of Medicine Dpt of Psychiatry, New Haven, Connecticut, United States

Prevalence of Carbohydrate Intolerance in Lean and Overweight/Obese Children

Not Applicable
Completed
Conditions
Obesity
Type 2 Diabetes
Interventions
Diagnostic Test: Oral Glucose tolerance test
First Posted Date
2013-10-23
Last Posted Date
2024-08-23
Lead Sponsor
Yale University
Target Recruit Count
2500
Registration Number
NCT01967849
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Genetics of Fatty Liver Disease in Children

Completed
Conditions
Non Alcoholic Fatty Liver Disease
Interventions
Other: ogtt
Other: genotyping
Other: abdominal and liver magnetic resonance imaging
Other: stool sample
Other: liver biopsy
First Posted Date
2013-10-21
Last Posted Date
2017-12-08
Lead Sponsor
Yale University
Target Recruit Count
381
Registration Number
NCT01966627
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents

Not Applicable
Completed
Conditions
Disruptive Behavior
Anger
Irritability
Noncompliance
Aggression
Interventions
Behavioral: Supportive Psychotherapy (SPT)
Behavioral: Cognitive-Behavioral Therapy for Anger and Aggression
First Posted Date
2013-10-18
Last Posted Date
2023-11-18
Lead Sponsor
Yale University
Target Recruit Count
101
Registration Number
NCT01965184
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

CHG Dressings in Children With Central Lines

Not Applicable
Terminated
Conditions
Children With Central Venous Access
Interventions
Other: Tegaderm CHG clear dressing
Other: Standard clear Tegaderm dressing
First Posted Date
2013-10-07
Last Posted Date
2016-05-13
Lead Sponsor
Yale University
Target Recruit Count
16
Registration Number
NCT01955226
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?

Early Phase 1
Terminated
Conditions
Type 1 Diabetes
Interventions
Device: Continuous glucose sensor
Device: Insupatch
First Posted Date
2013-10-01
Last Posted Date
2020-03-09
Lead Sponsor
Yale University
Target Recruit Count
11
Registration Number
NCT01954459
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy

Early Phase 1
Completed
Conditions
Type 1 Diabetes
Interventions
Device: ePID closed loop system
Drug: Lispro-PH20
First Posted Date
2013-09-18
Last Posted Date
2022-05-24
Lead Sponsor
Yale University
Target Recruit Count
13
Registration Number
NCT01945099
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

The Development of a Domestic Violence Perpetrator Collusion Measurement Tool

Not Applicable
Completed
Conditions
Intimate Partner Violence (IPV)
First Posted Date
2013-09-16
Last Posted Date
2023-08-30
Lead Sponsor
Yale University
Target Recruit Count
72
Registration Number
NCT01942616
Locations
🇺🇸

Michigan State University, East Lansing, Michigan, United States

🇺🇸

Yale University, New Haven, Connecticut, United States

🇺🇸

Loyola University New Orleans, New Orleans, Louisiana, United States

and more 1 locations

Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.

Phase 2
Completed
Conditions
Restless Leg Syndrome
Interventions
First Posted Date
2013-08-29
Last Posted Date
2016-03-21
Lead Sponsor
Yale University
Target Recruit Count
24
Registration Number
NCT01931878
Locations
🇺🇸

Yale Physcian Building, New Haven, Connecticut, United States

IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation

Phase 2
Terminated
Conditions
Pain
Interventions
First Posted Date
2013-08-29
Last Posted Date
2015-12-31
Lead Sponsor
Yale University
Target Recruit Count
12
Registration Number
NCT01931865
Locations
🇺🇸

Yale Physician Building, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath